about
MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCUE2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expressionOxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHLThe IKK complex contributes to the induction of autophagyControl of T(H)17/T(reg) balance by hypoxia-inducible factor 1Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2Mitochondrial metabolic remodeling in response to genetic and environmental perturbationsYour neighbours matter - non-autonomous control of apoptosis in development and diseaseTargeting Protein-Protein Interactions in the HIF SystemThe role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisHypoxia and metabolic properties of hematopoietic stem cellsUbiquitin-dependent regulation of Foxp3 and Treg functionHypoxia and Integrin-Mediated Epithelial Restitution during Mucosal InflammationUnexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor functionRole of the sympathetic autonomic nervous system in hypoxic remodeling of the fetal cerebral vasculatureThe Role of Hypoxia-Inducible Factor in Wound HealingC. elegans are protected from lethal hypoxia by an embryonic diapauseThe Hypoxic Regulator of Sterol Synthesis Nro1 Is a Nuclear Import AdaptorNovel insights into the molecular origins and treatment of lung cancerInsulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytesMitochondrial function in hypoxic ischemic injury and influence of agingEvidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factorsMetabolic adaptation to chronic inhibition of mitochondrial protein synthesis in acute myeloid leukemia cellsThe requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stabilityMYC on the path to cancerExploring the molecular basis of adaptive evolution in hydrothermal vent crab Austinograea alayseae by transcriptome analysis.An RNA interference screen identifies a novel regulator of target of rapamycin that mediates hypoxia suppression of translation in Drosophila S2 cells.Hydrogen sulfide increases hypoxia-inducible factor-1 activity independently of von Hippel-Lindau tumor suppressor-1 in C. elegans.Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.Post-translational modifications of connexin26 revealed by mass spectrometry.COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.Calcium mediates high glucose-induced HIF-1α and VEGF expression in cultured rat retinal Müller cells through CaMKII-CREB pathway.T-cell activation under hypoxic conditions enhances IFN-gamma secretion.Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formationDrosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxiaIs Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.Hypoxia-specific targets in cancer therapy: role of splice variantsThe role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.
P2860
Q21136391-8AFDFFD1-C4A7-4323-A7EB-CEBA38CEE4CFQ24296966-8E0D3094-512F-4692-9A99-DACC3A343FF8Q24306884-CBE58D0C-0A79-435D-9600-4B148E982EE4Q24311838-98B04007-9DFD-4D6C-9F4F-448B40836942Q24329117-83347AF6-382D-4A96-B571-7C76060F00F3Q24336199-63E04C04-EB54-4673-87DD-D2E1F972CC26Q24648959-6450C33C-5489-4580-9578-8BBF3D68805BQ26747718-B340729F-AD4B-43E7-8838-22BF72B53A90Q26749610-46374CFA-47BB-45D2-A1E7-E7B1F1936033Q26753176-703C4FD3-6084-41B6-84EB-41DC1A091B3FQ26797382-E5EA9C72-5629-46F6-9D5C-A6042122CF8DQ26853702-28FAA0E4-4530-44E9-BB83-4715B1215CC3Q26863525-8A306D65-9B6F-4FA9-B464-7046F1915A69Q26995631-2A78689A-CC96-4A02-8333-A174CAC3B4ADQ27000674-8101E16F-BD0F-4E66-AC82-5A0D7DF9A861Q27004355-2D8B702F-7EAD-4382-B320-D13486311B94Q27030833-C841A377-C845-45C8-8E67-9CC880DE2446Q27317135-91CDED9D-0258-4079-AE98-71A9A1C3FF91Q27667476-531C9B5D-77C4-4844-99EF-CD5B5CF8EFEFQ28386773-3231CE9D-6A37-4F34-B276-1347CF81CB8CQ28393534-56C57394-F628-4705-8C52-8804ED5CF151Q28396663-92BC2707-21D1-44E8-9034-D3F0F937D257Q28471913-6B96085B-E6D2-47F2-8E06-B870A3CC6CE7Q28487801-A94BE1B6-B56A-4828-9315-3549577DF8E6Q28727324-5C9C19AB-F999-4813-BB11-A522DCE5904CQ29619979-1305DD78-ECEB-4A72-A912-7BBDBBEAF469Q30354521-FDDFEBC9-0F7C-4C49-AFD6-B2065F4EBE4DQ30483779-4C4EC2D3-084A-4F19-82E8-7B5C34033711Q30492639-CF346E3E-6252-4380-8F08-9EF6C18214CEQ33376948-D8E9B778-CD6C-4EB3-BBFF-98D0C2482E8BQ33506159-0478F46D-0A92-45BE-92C4-1F6DCF56A91EQ33508581-86C5EC70-8CDB-4A7B-9964-6E057DE51666Q33571261-A88E58BD-0191-40DE-B1CA-9D1D1B9D616CQ33601904-4D60BFA9-17FE-4B19-BD5F-4C54183317A1Q33606893-4670EBE4-E092-4D2D-9CE2-17CEE07C6F3FQ33610630-ABEE4096-83F7-47C3-97F4-160B89A497BCQ33619194-695A4AE1-4A0D-4A99-B902-48038E456435Q33623036-7D1BF266-170F-466D-9BF1-EE4D502824DDQ33630837-11299D03-657F-47FD-8F16-4D39A848B2E0Q33631447-EC8B90A9-8ED8-473A-B5B9-09362BA25E33
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hypoxia-inducible factor 1 (HIF-1) pathway.
@en
type
label
Hypoxia-inducible factor 1 (HIF-1) pathway.
@en
prefLabel
Hypoxia-inducible factor 1 (HIF-1) pathway.
@en
P356
P1476
Hypoxia-inducible factor 1 (HIF-1) pathway.
@en
P356
10.1126/STKE.4072007CM8
P577
2007-10-09T00:00:00Z